Literature DB >> 29149334

Reassessing the Likely Harms to Kidney Vendors in Regulated Organ Markets.

Luke Semrau1.   

Abstract

Julian Koplin, drawing extensively on empirical data, has argued that vendors, even in well-regulated kidney markets, are likely to be significantly harmed. I contend that his reasoning to this conclusion is dangerously mistaken. I highlight two failures. First, Koplin is insufficiently attentive to the differences between existing markets and the regulated markets proposed by advocates. On the basis of this error, he wrongly concludes that many harms will persist even in a well-regulated system. Second, Koplin misunderstands the utilitarian assessment of the market. He focuses on the costs and benefits of the transaction for the vendor. But, the relevant comparison is between an individual's welfare across different courses of action, namely, vending and the nonvending alternative. Although Koplin's empirically informed contribution is a welcome addition to this literature, the mistakes that pervade his interpretation of the data demand correction.
© The Author 2017. Published by Oxford University Press, on behalf of the Journal of Medicine and Philosophy Inc. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Utilitarianism; harm; kidney markets; regulation

Mesh:

Year:  2017        PMID: 29149334     DOI: 10.1093/jmp/jhx025

Source DB:  PubMed          Journal:  J Med Philos        ISSN: 0360-5310


  2 in total

1.  Commodification and Human Interests.

Authors:  Julian J Koplin
Journal:  J Bioeth Inq       Date:  2018-05-25       Impact factor: 1.352

2.  Kidneys for Sale? A Commentary on Moeindarbari's and Feizi's Study on the Iranian Model.

Authors:  Frederike Ambagtsheer; Sean Columb; Meteb M AlBugami; Ninoslav Ivanovski
Journal:  Transpl Int       Date:  2022-06-24       Impact factor: 3.842

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.